PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,073,884 | -1.9% | 989,232 | 0.0% | 13.66% | +29.3% |
| Q2 2023 | $6,192,592 | +31.2% | 989,232 | 0.0% | 10.56% | +12.1% |
| Q1 2023 | $4,718,637 | -45.2% | 989,232 | 0.0% | 9.42% | -33.0% |
| Q4 2022 | $8,606,318 | -26.9% | 989,232 | 0.0% | 14.05% | -23.4% |
| Q3 2022 | $11,772,000 | -16.5% | 989,232 | 0.0% | 18.33% | -5.5% |
| Q2 2022 | $14,097,000 | -31.6% | 989,232 | 0.0% | 19.40% | +23.7% |
| Q1 2022 | $20,596,000 | -9.9% | 989,232 | 0.0% | 15.68% | +52.3% |
| Q4 2021 | $22,851,000 | – | 989,232 | – | 10.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |